Sean Jones Quaidoo, MD
Orthopaedic Surgery of the Spine · Dallas, TXNPI 1548473713
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $383,029 of the $550,255 with a category attached, or 69.6%. 52 manufacturers reported payments, led by Fuse Medical, Inc. at 38.0% of the total. Reporting peaked in 2019 at $131,962 and has fallen 55.8% since, to $58,316 in 2025. Among orthopaedic surgery of the spine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $2990.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fuse Medical, Inc.$209K
- Kyocera Medical Technologies, Inc.$192K
- Hyhte Holdings Inc.$102K
- Johnson & Johnson$25K
- Medical Device Business Services, Inc.$9K
- Eminent Spine, LLC$6K
- plus $7K from 46 others
What the payments were for
- Royalty or licence$134,57524%
- Consulting fees$383,02970%
- Travel & lodging$17,2253%
- Food & beverage$15,4273%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VISTASEAL$31,907
- STRATAFIX$24,932
- DERMABOND PRINEO$24,769
- SURGIFLO Hemostatic Matrix$24,769
- Olympic MIS$22,261
- SURGICEL NU-KNIT$7,081
- ECHELON ENDOPATH$6,975
- Eminent Spine's Diamondback Spinal System$5,665
- OptiMesh Graft Containment$1,175
- Proclaim IPG$458
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$275
- SPECTRA WAVEWRITER$248
- aprevo$204
- Magellan$175
- BIOFIX$173
- BIODRESTORE$173
- BIODFACTOR$173
- BIODOPTIX$173
- MEDIHONEY$173
- INTELLIS$165
How this compares
$550,255 in reported general payments places this provider in the 90th percentile of 207 orthopaedic surgery of the spine providers in Texas.
See all orthopaedic surgery of the spine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 54 | $1,495 |
| Gabapentin | 133 | $1,448 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $1,214 |
| Methylprednisolone | 131 | $975 |
| Baclofen | 61 | $916 |
| Methocarbamol | 18 | $385 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $95 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Dallas
- Andrew ClavennaDallas$1.3M
- William HotchkissDallas$510K
- Augustus RushDallas$140K
- Randall DryerAustin$2.9M
- Craig KuhnsAustin$2.4M
- David WimberleyHouston$2.2M
- Jeffrey PhelpsNorth Richland Hills$1.9M
- Eric WieserArlington$1.5M
- Ivan ChengKyle$1.2M
- Stephen TolhurstFlower Mound$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.